Abstract
Objective: To investigate the relationship between obstructive sleep apnea hypopnea syndrome (OSAHS), obesity, and oxidative stress markers in postmenopausal obese women. Methods: A total of 28 female patients participated in this experimental study. The patients were divided into three groups based on their classification in the Apnea-Hypopnea Index (AHI): G1 (11 individuals) with AHI ≤ 5 and BMI ≥ 29.9 kg/m2; G2 (9 individuals) with 5 ≥ AHI ≤ 15 and BMI ≥ 29.9 kg/m2; G3 (8 individuals) with AHI ≥ 15 and BMI ≥ 29.9 kg/m2. The production of superoxide, nitrites, and nitrates in these patients was evaluated and correlated with the AHI. Results: No significant differences were observed among the groups regarding the production of oxidative stress markers. Additionally, no significant correlations were found between the production of superoxide and serum levels of nitrites/nitrates and the apnea-hypopnea index (AHI) (r = 0.161; p = 0.074 and r = -0.357; p = 0.385, respectively). Conclusion: In postmenopausal obese women, there is no correlation between the severity of obstructive sleep apnea hypopnea syndrome and the evaluated oxidative stress markers. It is possible that the presence of untreated comorbidities and the distribution of body fat exert a greater influence on the production of free radicals in this population.
References
AASM. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep, 1999; 22: 667-689.
ALZOGHAIBI MA e BAHAMMAM AS. Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep and Bre, 2005; 9(3):119-26.
ARNAUD C, et al. Obstructive sleep apnoea and cardiovascular consequences: pathophysiological mechanisms. Archives of Cardiovascular Diseases, 2020; 113(5): 350-358.
BARCELÓ A, et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. European Respiratory Journal, 2006; 27(4):756–760.
DE SOUZA FS, et al. Síndrome da apneia e hipopneia obstrutiva do sono e principais comorbidades associadas. Revista de Ciências Médicas, 2020; 29: 1-9.
FIETZE I, et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences–Results of SHIP‐Trend. Journal of Sleep Research, 2019; 28(5): e12770.
GALLEGARIO TRS, et al. A influência do estresse e da obesidade na infertilidade feminina e sua análise evolutiva: uma visão integrativa The influence of stress and obesity on female infertility and its evolutionary analysis: an integrative vision. Brazilian Journal of Development, 2021; 7(10): 99637-99656.
GRASEMANN H e HOLGUIN F. Oxidative stress and obesity-related asthma. Paediatric Respiratory Reviews, 2021; 37: 18-21.
HARADA Y, et al. Differences in Associations between Visceral Fat Accumulation and Obstructive Sleep Apnea by Sex. American Thoracic Society, 2014: 28.
IANNELLA G, et al. Obstructive Sleep Apnea Syndrome: From Symptoms to Treatment. International. Journal of Environmental Research and Public Health, 2022; 19(4): 2459.
JAKUBIAK GK, et al. Oxidative stress in association with metabolic health and obesity in young adults. Oxidative. Medicine and Cellular Longevity, 2021; 2021: 1-19.
LEE JJ e SUNDAR KM. Evaluation and management of adults with obstructive sleep apnea syndrome. Lung, 2021; 199(2): 87-101.
LESSA RT, et al. A privação do sono e suas implicações na saúde humana: uma revisão sistemática da literatura. Revista Eletrônica Acervo Saúde, 2020; (56): e3846.
LIRA AB. Avaliação do estresse oxidativo na síndrome da apneia obstrutiva do sono e utilização de terapia oxidante. Tese (Doutorado em Ciências da Saúde) – Instituto de Ciências Biológicas e da Saúde. Universidade Federal de Alagoas, Maceió, 2020; 71 p.
MA XR, et al. Imbalance of osteoprotegerin/receptor activator of nuclear factor-κB ligand and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome. Chinese Medical Journal, 2019; 132(01): 25-29.
MALHOTRA A, et al. Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep, 2021; 44(7): zsab030.
MANIACI A, et al. Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients. Journal of Clinical Medicine, 2021; 10(2): 277.
MELIANTE PG, et al. Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea. International Journal of Molecular Sciences, 2023; 24(6): 5478.
NG SS, et al. Validation of Embletta portable diagnostic system for identifying patients with suspected obstructive sleep apnoea syndrome (OSAS). Respirology, 2010; 15(2): 336-42.
PERES BU, et al. Obstructive sleep apnea and circulating biomarkers of oxidative stress: a cross-sectional study. Antioxidants, 2020; 9(6): 476.
RAMANATHAN L, et al. Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport, 2002; 13:1387–1390.
SEQUEIRA AR. Biomarcadores de disfunção tubular em doenças cardiometabólicas. Dissertação (Mestrado em Tecnologias Clínico-Laboratoriais) - Escola Superior de Tecnologia da Saúde de Lisboa. Instituto Politécnico de Lisboa, Lisboa, 2022; 69 p.
SIMIAKAKIS M, et al. Lack of Effect of Sleep Apnea on Oxidative Stress in Obstructive Sleep Apnea Syndrome (OSAS) Patients. PLoS ONE, 2012; 7(6): e39172.
SIMPSON L, et al. Sex differences in the association of regional fat distribution with the severity of obstructive sleep apnea. Sleep, 2010; 33(4): 467-74.
SVATIKOVA A, et al. Oxidative stress in obstructive sleep apnoea. European Heart Journal, 2005; 26: 2435–2439.
WON CH, et al. Varying hypopnea definitions affect obstructive sleep apnea severity classification and association with cardiovascular disease. Journal of Clinical Sleep Medicine, 2018; 14(12): 1987-1994.
